Companion Diagnostics
News on companion diagnostics and drug/test co-development.
Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma
FoundationOneCDx will also automatically be a companion diagnostic for future BRAF inhibitors approved by the FDA that target specific BRAF mutations.
Merck, Burning Rock Ink Liquid Biopsy Companion Diagnostics Deal
The companies intend to develop Burning Rock's 168-gene OncoCompass Target test as a companion to Merck's MET inhibitor Tepmetko in mainland China.
Acrivon Therapeutics Raises $100M in Series B Funding
The company will use the funds to advance its CHK1/2 inhibitor ACR-368 and use its proteomics platform to develop companion tests.
Sysmex also recently formed a companion diagnostic development partnership with Qiagen, which could help with its efforts in this area.
I-Mab, Roche Diagnostics to Codevelop Companion Diagnostics in China
Under the collaboration, I-Mab and Roche will jointly develop companion diagnostics for I-Mab's assets under development.